证券记录 · 已归档季度
INCY
Incyte Corporation · Healthcare · Biotechnology
17被追踪持有人
0Δ持有人
35.50M持有股份
$2.35B报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +6.1% · 净新建仓位 0.0% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 433.49K | $48.73M | n/a | −2 |
| Q2 2026 | 154 | 0 | 131.73M | $14.93B | +4 | −5 |
| Q1 2026 | 158 | +1 | 132.61M | $12.47B | +5 | −5 |
| Q4 2025 | 156 | -1 | 139.13M | $13.74B | +1 | −1 |
| Q3 2025 | 24 | 0 | 89.63M | $7.60B | n/a | −1 |
| Q2 2025 | 22 | +1 | 88.20M | $6.01B | +1 | n/a |
| Q1 2025 | 18 | -1 | 44.33M | $2.68B | n/a | −1 |
| Q4 2024 | 19 | +1 | 43.85M | $3.03B | +1 | n/a |
| Q3 2024 | 17 | 0 | 35.50M | $2.35B | +1 | −1 |
| Q2 2024 | 17 | n/a | 33.47M | $2.03B | n/a | n/a |
持有人 · Q3 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 15.28M | 0.0% | $1.01B | 0.6% | ▼ Trim | 2 | SEC ↗ |
| 2 | Renaissance Technologies ✦ | 4.50M | -13.8% | $297.42M | 0.4% | ▼ Trim | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 3.94M | -2.7% | $259.33M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 4 | AQR Capital Management ✦ | 2.70M | +1.5% | $178.58M | 0.2% | ▲ Add | 2 | SEC ↗ ×3 |
| 5 | Point72 Asset Management ✦ | 2.37M | 新增 | $156.61M | 0.6% | New | 1 | SEC ↗ |
| 6 | Norges Bank ✦ (被动) | 1.68M | -20.8% | $111.25M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Marshall Wace ✦ | 1.28M | +3711.1% | $84.50M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 1.11M | -10.1% | $73.28M | 0.1% | ▼ Trim | 2 | SEC ↗ ×2 |
| 9 | Citadel Advisors ✦ | 781.28K | -4.9% | $51.64M | 0.1% | ▼ Trim | 2 | SEC ↗ ×2 |
| 10 | T. Rowe Price ✦ | 608.44K | +170.3% | $40.22M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 11 | Millennium Management ✦ | 565.19K | +34.5% | $37.36M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Bridgewater Associates ✦ | 308.63K | +142.8% | $20.40M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 13 | ARK Investment Management ✦ | 211.54K | -46.9% | $13.98M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 14 | Wellington Management ✦ | 71.73K | -59.0% | $4.74M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 15 | Gotham Asset Management ✦ | 65.39K | -18.4% | $4.32M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 20.58K | -90.6% | $1.36M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Fisher Asset Management ✦ | 11.52K | +24.4% | $761,603 | 0.0% | ▲ Add | 2 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $156.61M | 0.6% |
已清仓
| Capital World Investors | $24.01M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 805 持有人, 201.47M 股份, $18.13B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Oct 15
CAGNONI PABLO J
Officer · 2.64K 股 · $297,780
Sep 15
CAGNONI PABLO J
Officer · 13.98K 股 · $1.69M
Sep 15
CAGNONI PABLO J
Officer · 9.23K 股 · $1.11M
Aug 19
CAGNONI PABLO J
Officer · 10.80K 股 · $1.36M
Aug 12
CAGNONI PABLO J
Officer · 10.80K 股 · $1.30M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2024 ·
方法论 ·
通过API获取此数据